$ARWR

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (1y)
Win rate (1y)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ARWRSEC Form 4bearish
Sold 11,600 @ $87.30 avg · $1,012,680 · 2026-08-18

Form 4: PERRY MICHAEL S sold ARWR

PERRY MICHAEL S (Director at ARROWHEAD PHARMACEUTICALS, INC.) reported an open-market sale of 11,600 shares of ARWR at an average $87.30, roughly $1,012,680, in a Form 4 filed 2026-08-20.

View filing on SEC.gov →

End of results.